pharma · Diabetes Mellitus · Hemophilia A
Takeda
Takeda clinical programs — 393 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- Cambridge, USA
- Founded
- 1993
- Employees
- 1,617
- Programs
- 1179
- Drugs
- 359
- Patents
- 1436
Takeda projects
393 ClinicalTrials.gov programs sponsored by Takeda.
Takeda has 393 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
placebo
Takeda
Non-cancer Pain
1 trial -
prucalopride
Takeda
Functional Constipation
1 trial -
rVWF
Takeda
Von Willebrand Disease (VWD)
1 trial -
rozerem
Takeda
Insomnia
1 trial -
teduglutide 0.05 mg/kg/d
Takeda
Short Bowel Syndrome
1 trial -
trifluridine/tipiracil
Takeda
Metastatic Oesogastric Adenocarcinoma
1 trial -
velaglucerase alfa
Takeda
Gaucher Disease, Type 1
1 trial -
vitamin D
Takeda
COVID-19
1 trial -
von Willebrand factor (Recombinant)
Takeda
Von Willebrand Disease
1 trial
Frequently asked questions
How many clinical projects does Takeda have?
393 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.